SCHEMBL4288666

SCHEMBL4288666

COc1ccc(C(=O)c2c(O)cc(COC(C)=O)cc2Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
MAPT P10636 2/20 0.46
RAB9A P51151 2/20 0.46
LMNA P02545 2/20 0.46
MAPK1 P28482 2/20 0.46
MEN1 O00255 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
CYP2D6 P10635 3/20 0.44
CYP2C19 P33261 3/20 0.44
CYP3A4 P08684 2/20 0.44
SLC5A1 P13866 1/20 0.44
SLC5A2 P31639 1/20 0.44
SLC22A12 Q96S37 3/20 0.42
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4279701 0.86 CYP3A4 (0.54) KMT2AMAPTRAB9ALMNAMAPK1
SCHEMBL4279702 0.85 NFKB1 (0.45) KMT2AMAPTRAB9ALMNAMAPK1
SCHEMBL4285302 0.85 HPGD (0.46) KMT2AMAPTRAB9ALMNAMAPK1
SCHEMBL4287423 0.84 MEN1 (0.50) KMT2AMAPTRAB9ALMNAMAPK1
SCHEMBL4292221 0.77 MEN1 (0.54) KMT2AMAPTRAB9ALMNAMAPK1
SCHEMBL4279710 0.73 MAOB (0.48) KMT2AMAPTRAB9ALMNAMAPK1
SCHEMBL4288165 0.73 ALDH1A1 (0.48) KMT2AMAPTRAB9ALMNAMAPK1
SCHEMBL112518 0.73 ALDH1A1 (0.62) MAPTRAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL1871228 0.73 ALDH1A1 (0.62) MAPTRAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL4292523 0.72 PARP10 (0.43) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 KMT2A 1397/4885MAPT 2884/4885RAB9A 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.